Engin Sebin

Engin Sebin

Auto-generated profile, based on publicly available information

Engin Sebin

Medical Biochemistry- Erzurum Regional Education and Training Hospital, Erzurum, Turkey

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 December 2020 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
FBFevzi Bedir
Fevzi Bedir
HKHÜSEYİN KOCATÜRK
HÜSEYİN KOCATÜRK
MAMehmet Sefa Altay
Mehmet Sefa Altay
EŞEngin Şebi̇n
Engin Şebi̇n
BBBanu Bedi̇r
Banu Bedi̇r
To examine serum paraoxonase 1 and 3 (PON1 and PON 3) activities in benign and malignant diseases of the prostate, to determine lipid profile and malondialdehyde (MDA) levels, and to investigate changes in levels following robotic-assisted laparoscopic radical prostatectomy (RALRP). 137 patients, including a control group, were enrolled in the study. These were assigned into four groups. Group 1 (n=33) consisted of previously undergoing RALRP with no recurrence, Group 2 (n=36) of patients diagnosed with prostate cancer (PCa) and undergoing RALRP, and Group 3 (n=34) of patients diagnosed with benign prostatic hyperplasia. The control group (n=34) consisted of healthy individuals. Serum Low-Density Lipoprotein (LDL), High-Density Lipoprotein (HDL), triglyceride, cholesterol, prostate-specific antigen (PSA), PON1, PON3, and MDA values were measured. In addition, Group 2 MDA, PON1, PON3, and PON1/HDL levels were investigated preoperatively and at the first month postoperatively. Significant changes were determined in PON1, PON3 and MDA levels. PON1 and PON3 levels decreased significantly in patients with PCa, while MDA levels increased. PON1 and PON3 increased postoperatively in the PCa group, while MDA decreased. BPH group PON1, PON3 and MDA levels were higher than those of the control group. An increase in free oxygen radicals in the body or a decrease in endogenous antioxidant enzyme levels can result in malignant and benign diseases of the prostate. Surgical excision of malignant tissue in PCa causes a decrease in oxidative stress.

3 January 2023 in Jundishapur Journal of Microbiology
Verified
Journal Article
Open access
PDF file
EKEmine Fusun Karasahin
Emine Fusun Karasahin
ESEngin Sebin
Engin Sebin
IŞIrem akın şen
Irem akın şen
OKOmer Karasahin
Omer Karasahin
Background: SARS-CoV-2 infections (COVID-19) first occurred in Wuhan, China, in December 2019 and spread worldwide, causing significant mortality and morbidity. IL-17A may mediate numerous immunopathological effects secondary to cytokine release syndrome during SARS-CoV-2 infection. However, there has not been enough research on its effect on prognosis. Objectives: This study evaluated the predictive power of serum interleukin (IL)-17A level as a prognostic marker in COVID-19. Methods: The study included 152 patients diagnosed with COVID-19 by real-time polymerase chain reaction analysis of nasopharyngeal swab samples in the infectious diseases department and intensive care unit of our hospital between October 1 and December 31, 2020. The control group consisted of 40 asymptomatic healthcare workers who had negative RT-PCR results during routine COVID-19 screening in our hospital. Samples were collected in anticoagulant-free tubes and left at room temperature for 30 minutes. Afterward, it was centrifuged at 1000 × g for 15 minutes at 4°C per the instructions provided with the enzyme-linked immunoassay (ELISA) kit. Serum IL-17A levels were measured using the Human Interleukin 17A ELISA Kit. Results: Serum IL-17A levels were significantly higher in COVID-19 patients than in controls (P < 0.001). IL-17A levels increased significantly in association with disease severity in patients with the moderate, severe, and critical disease, with a less pronounced difference between severe and critical patients (moderate vs. severe, P < 0.001; severe vs. critical, P = 0.048). IL-17A levels at hospital admission and day 7 were significantly higher in non-surviving patients (P < 0.001). At a cut-off value of 210.25 ng/L, IL-17A at admission had a predictive power of 0.792 (P < 0.001). Compared to baseline, IL-17A values on day seven were significantly increased in non-survivors (P = 0.004) and decreased in survivors (P = 0.014). An increase of 26.17 ng/L or more on day 7 had a predictive mortality power of 0.634 (P = 0.005). Conclusions: The results of this study suggest that IL-17A, an important part of the immune system previously shown to be useful in the treatment and follow-up of COVID-19, may also help predict mortality in COVID-19 patients.

27 May 2024 in New Trends in Medicine Sciences
Verified
Journal Article
Open access
PDF file
ATAyhan Tanyeli
Ayhan Tanyeli
MGMustafa Can Güler
Mustafa Can Güler
EEErsen Eraslan
Ersen Eraslan
SSSaime Ozbek Sebin
Saime Ozbek Sebin
BBBurak Bircan
Burak Bircan
FAFazile Nur Ekinci Akdemir
Fazile Nur Ekinci Akdemir
Testicular ischemia-reperfusion (T I/R) injury leads to oxidative stress with excessive accumulation of reactive oxygen species in the tissue. This phenomenon has an important place in the pathophysiology of testicular torsion injury. In the presented study, it was aimed to reveal the prophylactic beneficial effects of apelin 13 (APE-13 ) on T I/R damage. Twenty-four male Sprague Dawley rats were randomly divided into four groups as sham, I/R, 10µg/kg APE-13 and 100µg/kg groups. I/R protocol and apelin 13 application doses were applied with reference to previous studies. At the end of the experiment, all rats were sacrificed and their testicular tissues were quickly removed. It was stored under appropriate conditions until biochemical analysis was performed. In the biochemical analysis of the tissues, it was determined that oxidative parameters and inflammatory cytokine levels increased and antioxidant levels decreased in the testicular tissue due to I/R. On the other hand, it was observed that these results changed significantly in the 10µg/kg APE-13 and 100µg/kg groups. Considering the presented data, it was revealed that the severity of T I/R-induced tissue damage was reduced when APE-13 was administered at doses of 10µg/kg and 100µg/kg.

30 January 2024 in European Journal of Sport Science
Verified
Journal Article
Open access
SSSaime Ozbek Sebin
Saime Ozbek Sebin
ESEngin Sebin
Engin Sebin
CGCebrail Gençoğlu
Cebrail Gençoğlu
SÖSerhat ÖZBAY
Serhat ÖZBAY
SUSLYMN ULPNR
SLYMN ULPNR
KAKonca Altinkaynak
Konca Altinkaynak
Aerobic exercise is recommended by clinicians in the prevention and treatment of metabolic diseases. The aim of this study is to investigate the effect of aerobic exercise in cold weather on CTRP‐3 levels and its potential implications for metabolic diseases. Twenty‐seven healthy young individuals (age = 22.1 ± 1.7 years, BMI = 22.2 ± 1.3, and n = 27; 13 female and 14 male) voluntarily participated in this study. Participants performed 40 min aerobic running exercise at 0, 12, and 20°C environmental temperatures. Our study demonstrates that 40 min of aerobic exercise at temperatures of 0 and 12°C significantly increased CTRP‐3 levels in athletes, while no significant change was observed at 24°C. The main findings indicated significant differences between pre‐and post‐exercise CTRP‐3 values for 0°C (p = 0.001) and 12°C (p = 0.005) environmental temperature, whereas no significant difference was found at 24°C (p = 0.148). Additionally, two‐way ANOVA revealed that both the temperature (0, 12, and 24°C) and exercise (pre‐ and post‐) affect serum CTRP‐3 levels (p = 0.023). CTRP‐3 elevation from baseline to post‐exercise in the 0°C, 12°C, and 24°C were +23.4%, +10.6%, and +8.1%, respectively. These findings suggest that engaging in aerobic exercise in cold weather conditions may serve as an effective intervention against metabolic disorders, including diabetes and obesity. The significant increases in CTRP‐3 levels following aerobic exercise in cold weather conditions justify the need for further, more extensive studies to assess their potential impact on metabolic diseases, as well as cartilage and bone formation.

30 April 2021 in Düzce Tıp Fakültesi Dergisi
Verified
Journal Article
Open access
PDF file
KKKadir Küçükceran
Kadir Küçükceran
OKOmer Karasahin
Omer Karasahin
ODOrhan Deli̇ce
Orhan Deli̇ce
ABAli Batur
Ali Batur
SYSibel Iba Yilmaz
Sibel Iba Yilmaz
MŞMahmut Şenyurt
Mahmut Şenyurt
Aim: The urokinase-type plasminogen activator (uPA) system consists of a protease, a receptor (urokinase-type plasminogen activator receptor, uPAR), and inhibitors that can be expressed on various cell types. Previous literature shows that the amount of soluble urokinase-type plasminogen activator receptor (suPAR) secreted from affected cells is higher in Crimean-Congo hemorrhagic fever (CCHF) patients than in healthy controls. Thus, we aimed to investigate the diagnostic value of suPAR in the differential diagnosis of CCHF in emergency services. Material and Methods: Individuals over 16 years old with a preliminary diagnosis of CCHF disease were divided into two groups as real time-polymerase chain reaction (RT-PCR) and/or IgM positive (CCHF group) and RT-PCR and/or IgM negative (control group). Results: Eighty patients were included in this study. Forty patients with CCHF virus PCR and/or CCHF virus IgM were identified as CCHF group and 40 patients included as negative control group. The median age of the patients was 45 (range, 16-91) years, and 49 patients (61.3%) were male. Leukocyte, platelet, and fibrinogen levels were significantly lower, while creatinine kinase, aPTT, and D-dimer levels were significantly higher in CCHF group. There was no statistically significant difference between the control group and CCHF group for SuPAR (p=0.386). In addition, control group patients not diagnosed with CCHF were examined, brucellosis, influenza, and pneumonia were found to be the most common. Conclusion: The use of suPAR as a biomarker in the differentiation of patients with similar findings in emergency services was investigated and found to have no diagnostic value.

31 July 2024 in Pediatric Practice and Research
Verified
Journal Article
Open access
PDF file
ÖTÖmer Topdağı
Ömer Topdağı
MGMustafa Can Güler
Mustafa Can Güler
EEErsen Eraslan
Ersen Eraslan
FAFazile Nur Ekinci Akdemir
Fazile Nur Ekinci Akdemir
ATAyhan Tanyeli
Ayhan Tanyeli
EŞEngin Şebin
Engin Şebin
Aim: This study aims to reveal the effects of two doses of apigenin (API) against renal ischemia-reperfusion injury (R I/R). Material and Methods: For this purpose, 5 and 10 mg/kg doses of API were preferred in our study, and the groups were designed as sham, R I/R, 5 mg/kg API, and 10 mg/kg API groups for the implementation of the experimental protocol. In the R I/R model, 1-hour ischemia and 24-hour reperfusion periods were preferred. Oxidative and inflammatory markers were measured biochemically in samples taken at the end of the experiment. Results: Biochemical results showed that oxidative and inflammatory markers increased significantly in the R I/R group, but antioxidant activities decreased significantly. In the 5 and 10 mg/kg API groups, R I/R damage was alleviated considerably, with these markers approaching the sham group values. Conclusion: As a result, the study's results determined that two different doses of API were effective against R I/R-induced kidney damage.